Sugimori, M., Hirotani, A., Yamazaki, H., Oshi, M., Kawashima, K., Tsuchiya, H., . . . Maeda, S. Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: Prognostic significance of TP53 status in gemcitabine plus nab-paclitaxel therapy. Elsevier.
Chicago Style (17th ed.) CitationSugimori, M., et al. Real-world Evidence of Chemotherapy Effects in Advanced Pancreatic Ductal Adenocarcinoma: Prognostic Significance of TP53 Status in Gemcitabine Plus Nab-paclitaxel Therapy. Elsevier.
MLA (9th ed.) CitationSugimori, M., et al. Real-world Evidence of Chemotherapy Effects in Advanced Pancreatic Ductal Adenocarcinoma: Prognostic Significance of TP53 Status in Gemcitabine Plus Nab-paclitaxel Therapy. Elsevier.
Warning: These citations may not always be 100% accurate.